Dr. Gupta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 984-974-1275Fax+1 984-974-8607
Summary
- Dr. Gaorav Gupta is a radiation oncologist in Chapel Hill, NC and is affiliated with University of North Carolina Hospitals. He received his medical degree from Weill Cornell Medical College of Cornell University and has been in practice 9 years. He specializes in breast cancer.
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2009 - 2013
Weill Cornell MedicineClass of 2008
Certifications & Licensure
NC State Medical License 2015 - 2025
NY State Medical License 2009 - 2016- American Board of Radiology Radiation Oncology
Clinical Trials
- Circulating Tumor Cells in Solid Tumors Start of enrollment: 2011 Dec 09
- Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast Cancer Start of enrollment: 2017 Jan 13
- Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma Start of enrollment: 2020 Jan 14
Publications & Presentations
PubMed
- 3134 citationsCancer Metastasis: Building a FrameworkGaorav P. Gupta, Joan Massagué
Cell. 2006-11-17 - 19 citationsDual inhibition of DNA-PK and DNA polymerase theta overcomes radiation resistance induced by p53 deficiency.Rashmi Kumar, Hui Xiao Chao, Dennis A. Simpson, Wanjuan Feng, Min-Guk Cho
NAR Cancer. 2020-12-21 - 10 citationsTargeting Non-homologous and Alternative End Joining Repair to Enhance Cancer Radiosensitivity.Wanjuan Feng, Chelsea M. Smith, Dennis A. Simpson, Gaorav P. Gupta
Seminars in Radiation Oncology. 2022-01-01
Press Mentions
Ramsden, Gupta Awarded 5-Year, $8.8 Million Grant to Study an Enzyme That Has Important Implications for Breast and Ovarian CancerSeptember 8th, 2020
Blood Test Accurately Identifies HPV-Related Head and Neck Cancer Recurrence; Prospective Clinical Study Published in Journal of Clinical OncologyFebruary 5th, 2020
Researchers Report Favorable Survival, Fewer Side Effects After Reduced Therapy for HPV-Linked Head and Neck CancerSeptember 13th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
